Yomna M Nassar

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Oxide Nanoparticles

Placebo Controlled

Top Venues

CPT: pharmacometrics & systems pharmacology

Clinical pharmacokinetics

This page only lists publications with an associated author ORCID identifier.

Publications

Francis Williams Ojara, Andrea Henrich, Nicolas Frances, Yomna M Nassar, Wilhelm Huisinga, Niklas Hartung, Kimberly Geiger, Stefan Holdenrieder, Markus Joerger, Charlotte Kloft
A prognostic baseline blood biomarker and tumor growth kinetics integrated model in paclitaxel/platinum treated advanced non-small cell lung cancer patients. CPT: pharmacometrics & systems pharmacology (2023)
Yomna M Nassar, Francis Williams Ojara, Alejandro Pérez-Pitarch, Kimberly Geiger, Wilhelm Huisinga, Niklas Hartung, Robin Michelet, Stefan Holdenrieder, Markus Joerger, Charlotte Kloft
C-Reactive Protein as an Early Predictor of Efficacy in Advanced Non-Small-Cell Lung Cancer Patients: A Tumor Dynamics-Biomarker Modeling Framework. Cancers 15 (22) (2023)
Yomna M Nassar, Nicolas Hohmann, Robin Michelet, Katharina Gottwalt, Andreas D Meid, Jürgen Burhenne, Wilhelm Huisinga, Walter Emil Haefeli, Gerd Mikus, Charlotte Kloft
Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous Infusion. Clinical pharmacokinetics 61 (11) (2022)